Feasibility and Efficacy of Adjuvant Chemotherapy With Gemcitabine After Liver Transplantation for Perihilar Cholangiocarcinoma-A Multi-Center, Randomized, Controlled Trial (pro-duct001)

Schmelzle, Moritz; Benzing, Christian; Fischer, Lutz; Herden, Uta; Sterneck, Martina; Settmacher, Utz; Bauschke, Astrid; Neumann, Ulf; Pelzer, Uwe; Mueller, Tobias; Strassburg, Christian; Lang, Hauke; Becker, Thomas; Koenigsrainer, Alfred; Nadalin, Silvio; Quante, Markus; Paul, Andreas; Friess, Helmut; Klempnauer, Juergen; Richter, Nicolas; Vondran, Florian; Pascher, Andreas; Roesch, Thomas; Schoening, Wenzel; Krenzien, Felix; Oellinger, Robert; Seehofer, Daniel; Neuhaus, Peter; Pratschke, Johann

Feasibility and Efficacy of Adjuvant Chemotherapy With Gemcitabine After Liver Transplantation for Perihilar Cholangiocarcinoma-A Multi-Center, Randomized, Controlled Trial (pro-duct001)

Autor(en):

Schmelzle, Moritz; Benzing, Christian; Fischer, Lutz; Herden, Uta; Sterneck, Martina; Settmacher, Utz; Bauschke, Astrid; Neumann, Ulf; Pelzer, Uwe; Mueller, Tobias; Strassburg, Christian; Lang, Hauke; Becker, Thomas; Koenigsrainer, Alfred; Nadalin, Silvio; Quante, Markus; Paul, Andreas; Friess, Helmut; Klempnauer, Juergen; Richter, Nicolas; Vondran, Florian; Pascher, Andreas; Roesch, Thomas; Schoening, Wenzel; Krenzien, Felix; Oellinger, Robert; Seehofer, Daniel; Neuhaus, Peter; Pratschke, Johann

Tübinger Autor(en):

Nadalin, Silvio
Quante, Markus
Königsrainer, Alfred

Erschienen in:

Frontiers in Oncology (2022), Bd. 12, Article 910871

Verlagsangabe:

Frontiers Media Sa

Sprache:

Englisch

Referenz zum Volltext:

http://dx.doi.org/10.3389/fonc.2022.910871

ISSN:

2234-943X